CoA Therapeutics
CoA Therapeutics was founded in 2018 with the aim of harnessing advances in understanding of the CoA pathway to develop novel therapies for difficult to treat and rare genetic disorders. CoA Therapeu...load more
CoA Therapeutics's Basic Information
CoA Therapeutics's Competitors
Bluebird Biosciences INC
View all employeesGreenway Lawn Aeration
View all employeesNBCL - Novel Biomarkers Catalyst Lab
View all employeesEmployee Insights
CoA Therapeutics's Top Employees
Anna Wade
Vice President OF BD AND Operations
Phone Email
Tessa Forbes
Senior Director, Clinical Operations
Phone Email
Jennifer Pavillard
Head Of Regulatory Affairs
Phone Email
Frequently Asked Questions Regarding CoA Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts